Case Study on Rapid Management of Dyslipidaemia and Hypertension Using Evidence-Based Ayurvedic Intervention

Year : 2025 | Volume : 14 | Issue : 03 | Page : 45 51
By

Niraj D Mendpara,

Rushabh N Vora,

  1. Assistant Professor, Department of Rasashastra and Bhaishajya Kalpana, Shri VM Mehta institute of Ayurved, Gardi vidhyapith, Director and chief physician at Aatreya Ayurved health care, Gujarat, India
  2. Assistant Professor, Department of Kayachikitsa, Shri VM Mehta institute of Ayurved, Gardi vidhyapith, Director and chief physician at Aatreya Ayurved health care, Rajkot, Gujarat, India

Abstract

Dyslipidemia and hypertension are common lifestyle disorders that significantly increase the risk of cardiovascular complications. In Ayurveda, these conditions may be correlated with Kapha Prakopa (Kapha Dosha aggravation) and Medo Dushti (Meda Dhatu visitation). A 43-year-old male presented with a history of dyslipidemia for 1 year and hypertension for 4 years. He had been on conventional antihypertensive medication for 4 years. The patient sought Ayurvedic management and discontinued all allopathic medications at the onset of Ayurvedic treatment. The patient was treated with Shadadharana Yoga, Varunadi Kwatha Ghana tablets, and medicated water prepared with Guduchi (Tinospora cordifolia), Shunthi (Zingiber officinale) and Dhanyaka (Coriandrum sativum). Lifestyle and dietary modifications were also advised. Normalization of blood pressure was observed within 2 days. Lipid profile parameters gradually improved and returned to normal within 5 weeks. The patient remained completely asymptomatic with no recurrence of clinical complaints throughout a 6-month follow-up period. Serial monitoring of biochemical parameters revealed a stable lipid profile, with maintained reductions in serum triglycerides, total cholesterol, and LDL levels, even after the discontinuation of Ayurvedic medications. This sustained improvement suggests that the therapeutic benefits of the intervention were not merely transient but contributed to long-term metabolic stabilization. Such findings highlight the potential of evidence-based Ayurvedic interventions not only to achieve effective short-term control of dyslipidemia and hypertension but also to promote enduring improvements in cardiovascular risk profiles, reduce dependence on long-term pharmacotherapy, and enhance patient quality of life. More case studies are required for elucidate the underlying mechanisms by which Ayurvedic therapies exert their long-lasting effects on lipid metabolism and blood pressure regulation.

Keywords: Cholesterol, dyslipidaemia, hypertension, Evidence, Ayurveda

[This article belongs to Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy ]

How to cite this article: Niraj D Mendpara, Rushabh N Vora. Case Study on Rapid Management of Dyslipidaemia and Hypertension Using Evidence-Based Ayurvedic Intervention. Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2025; 14(03):45-51.
How to cite this URL: Niraj D Mendpara, Rushabh N Vora. Case Study on Rapid Management of Dyslipidaemia and Hypertension Using Evidence-Based Ayurvedic Intervention. Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2025; 14(03):45-51. Available from: https://journals.stmjournals.com/joayush/article=2025/view=261063

References

  1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005 Oct 25;112(17):2735–52.
  2. Charaka Saṁhitā, Sutrasthana, Chapter 20, Verse 17. In: Yadavji Trikamji Acharya, editor. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2011. p. 112.
  3. Charaka Saṁhitā, Chikitsasthana, Chapter 6, Verse 15. In: Yadavji Trikamji Acharya, editor. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2011. p. 377.
  4. Charaka Saṁhitā, Chikitsasthāna, Chapter 15, Verse 44. In: Yadavji Trikamji Acharya, editor. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2011. p. 512.
  5. Charaka Saṁhitā, Sutrasthāna, Chapter 28, Verse 9. In: Yadavji Trikamji Acharya, editor. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2011. p. 181.
  6. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Dyslipidemia as a risk factor for hypertension. Curr Hypertens Rep. 2010;12(5):319–25.
  7. Vāgbhaṭa. Aṣṭāṅgahṛdaya, Chikitsasthāna, Chapter 8, Verse 34. In: Harishastri Paradkar Vaidya, editor. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2015. p. 538.
  8. Vāgbhaṭa. Aṣṭāṅgahṛdaya, Sūtrasthāna, Chapter 15, Verse 26. In: Harishastri Paradkar Vaidya, editor. Reprint ed. Varanasi: Chaukhambha Surbharati Prakashan; 2015. p. 116.
  9. Grundy SM. A constellation of complications: The metabolic syndrome. Clin Cornerstone. 2005 Jan 1;7(2-3):36–45.
  10. McCarron RM, Keenan CR. The metabolic syndrome. Managing metabolic abnormalities in the psychiatrically ill. Washington, DC: American Psychiatric Publishing, Inc.; 2007. p. 25–52.

Regular Issue Subscription Case Study
Volume 14
Issue 03
Received 13/08/2025
Accepted 17/09/2025
Published 18/09/2025
Publication Time 36 Days


Login

My IP

PlumX Metrics

Support